Logo image of CHRS

COHERUS ONCOLOGY INC (CHRS) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:CHRS - US19249H1032 - Common Stock

1.59 USD
-0.05 (-3.05%)
Last: 1/22/2026, 7:07:15 PM
1.7388 USD
+0.15 (+9.36%)
After Hours: 1/22/2026, 7:07:15 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CHRS revenue by date.CHRS revenue by date.
211M
-35.39%
257.244M
21.92%
266.96M
3.78%
44.63M
-83.28%
74.671M
67.31%
98.247M
31.57%
189.56M
92.94%
267.72M
41.23%
374.79M
39.99%
499.5M
33.27%
636.58M
27.44%
792.78M
24.54%
EBITDA
YoY % growth
CHRS ebitda by date.CHRS ebitda by date.
-253.2M
2.76%
-194.508M
23.18%
-92.891M
52.24%
-180.54M
-94.36%
-119.779M
33.66%
-55.549M
53.62%
-78.54M
-41.39%
-55.08M
29.87%
-25.5M
53.70%
-14.28M
44.00%
-4.08M
71.43%
N/A
EBIT
YoY % growth
CHRS ebit by date.CHRS ebit by date.
-256.9M
2.65%
-198.299M
22.81%
-98.167M
50.50%
-173.179M
-76.41%
-129.299M
25.34%
-112.428M
13.05%
-125.859M
-11.95%
-79.285M
37.00%
46.562M
158.73%
135.29M
190.56%
233.03M
72.24%
345.5M
48.26%
Operating Margin
CHRS operating margin by date.CHRS operating margin by date.
-121.75%-77.09%-36.77%-388.03%-173.16%-114.43%-66.40%-29.61%12.42%27.09%36.61%43.58%
EPS
YoY % growth
CHRS eps by date.CHRS eps by date.
-3.03
-163.48%
-2.02
33.33%
-0.75
62.87%
-1.47
-95.39%
-0.98
33.46%
-0.85
12.66%
-1.14
-34.13%
-0.93
18.75%
0.13
114.29%
0.57
330.77%
1.16
103.57%
1.79
53.51%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.36
-27.50%
-0.24
30.06%
-0.15
55.00%
-0.25
23.76%
-0.17
53.33%
Revenue
Q2Q % growth
14.477M
-73.26%
17.31M
127.79%
31.181M
204.09%
22.1M
90.99%
22.703M
56.82%
EBITDA
Q2Q % growth
-42.84M
-41.53%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-33.32M
6.26%
-25.145M
44.66%
-29.388M
35.39%
-29.275M
33.97%
-29.4M
11.76%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.33
-3,200.00%
-0.330.000.45%
Q2 2025
Q2Q % growth
-0.34
-142.86%
-0.30-0.04-12.36%
Q1 2025
Q2Q % growth
-0.35
-9.37%
-0.24-0.11-47.90%
Q4 2024
Q2Q % growth
-0.28
54.84%
-0.13-0.15-108.91%
Q3 2024
Q2Q % growth
-0.01
96.30%
-0.140.1392.65%
Q2 2024
Q2Q % growth
-0.14
63.16%
-0.300.1652.67%
Q1 2024
Q2Q % growth
-0.32
57.33%
-0.25-0.07-29.75%
Q4 2023
Q2Q % growth
-0.62
-3.33%
-0.12-0.50-410.06%
Q3 2023
Q2Q % growth
-0.27
71.88%
-0.280.013.63%
Q2 2023
Q2Q % growth
-0.38
19.15%
-0.490.1123.14%
Q1 2023
Q2Q % growth
-0.75
25.00%
-0.58-0.17-28.45%
Q4 2022
Q2Q % growth
-0.60
-30.43%
-0.850.2529.82%
Q3 2022
Q2Q % growth
-0.96
-182.35%
-0.58-0.38-65.12%
Q2 2022
Q2Q % growth
-0.47
-30.56%
-0.650.1828.05%
Q1 2022
Q2Q % growth
-1.00
-10,100.00%
-0.49-0.51-103.19%
Q4 2021
Q2Q % growth
-0.46
-483.33%
-0.520.0611.92%
Q3 2021
Q2Q % growth
-0.34
-203.03%
-0.22-0.12-51.52%
Q2 2021
Q2Q % growth
-0.36
-151.43%
-0.15-0.21-135.29%
Q1 2021
Q2Q % growth
0.01
-98.15%
0.07-0.06-85.70%
Q4 2020
Q2Q % growth
0.12 0.23-0.11-47.83%
Q3 2020
Q2Q % growth
0.33 0.41-0.08-20.21%
Q2 2020
Q2Q % growth
0.70 0.340.36105.06%
Q1 2020
Q2Q % growth
0.54 0.57-0.03-4.85%
CHRS Yearly EPS VS EstimatesCHRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -2 -4 -6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
11.571M
-83.65%
13.681M-2.11M-15.42%
Q2 2025
Q2Q % growth
10.254M
-84.22%
10.338M-84K-0.81%
Q1 2025
Q2Q % growth
7.599M
-90.14%
55.753M-48.154M-86.37%
Q4 2024
Q2Q % growth
54.144M
-40.84%
48.215M5.929M12.30%
Q3 2024
Q2Q % growth
70.774M
-5.09%
60.415M10.359M17.15%
Q2 2024
Q2Q % growth
64.979M
10.67%
62.593M2.386M3.81%
Q1 2024
Q2Q % growth
77.063M
137.58%
81.853M-4.79M-5.85%
Q4 2023
Q2Q % growth
91.524M
101.59%
98.328M-6.804M-6.92%
Q3 2023
Q2Q % growth
74.568M
64.25%
84.363M-9.795M-11.61%
Q2 2023
Q2Q % growth
58.716M
-2.47%
54.995M3.721M6.77%
Q1 2023
Q2Q % growth
32.436M
-46.03%
48.386M-15.95M-32.96%
Q4 2022
Q2Q % growth
45.4M
-38.15%
52.248M-6.848M-13.11%
Q3 2022
Q2Q % growth
45.4M
-44.97%
58.048M-12.648M-21.79%
Q2 2022
Q2Q % growth
60.2M
-31.28%
63.123M-2.923M-4.63%
Q1 2022
Q2Q % growth
60.1M
-27.59%
70.331M-10.231M-14.55%
Q4 2021
Q2Q % growth
73.4M
-33.51%
87.526M-14.126M-16.14%
Q3 2021
Q2Q % growth
82.5M
-27.38%
93.135M-10.635M-11.42%
Q2 2021
Q2Q % growth
87.6M
-35.45%
89.943M-2.343M-2.60%
Q1 2021
Q2Q % growth
83M
-28.57%
97.923M-14.923M-15.24%
Q4 2020
Q2Q % growth
110.4M 117.43M-7.03M-5.99%
Q3 2020
Q2Q % growth
113.6M 125.34M-11.74M-9.37%
Q2 2020
Q2Q % growth
135.7M 107.05M28.65M26.76%
Q1 2020
Q2Q % growth
116.2M 121.91M-5.71M-4.68%
CHRS Yearly Revenue VS EstimatesCHRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.72% -66.67% 1.6% -17.28%
Revenue0% -9.97% 0% -5.42%